Aandelen in “Gezondheidstechnologie”

Aandeel Datum Koers Evolutie
Even geduld...

Nieuws over “Gezondheidstechnologie”

11/03 · Nyxoah to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference · Persbericht

11/03 · Nyxoah to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference · Persbericht

11/03 · Precigen to Announce Full Year 2025 Financial Results and Provide Business Updates on March 25 · Persbericht

11/03 · Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons · Persbericht

11/03 · DOMA Perpetual Nominates Three Highly Qualified Candidates for the Board of Pacira BioSciences, Inc. · Persbericht

11/03 · GUERBET : Change in Guerbet’s Board of Directors. · Persbericht

11/03 · GUERBET : 2025 full-year results. · Persbericht

11/03 · REGENXBIO REPORTS NEW POSITIVE INTERIM DATA FROM PHASE I/II AFFINITY DUCHENNE® TRIAL OF RGX-202 · Persbericht

11/03 · Philips expands digital pathology portfolio with cloud-enabled Philips IntelliSite Pathology Solution on HealthSuite · Persbericht

11/03 · Abbott and Real Madrid launch nationwide effort to build the next 'Abbott Dream Team' · Persbericht

11/03 · RGNX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds REGENXBIO (RGNX) Investors of Securities Class Action Deadline on April 14, 2026 · Persbericht

11/03 · MREO SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Mereo (MREO) Investors of Securities Class Action Deadline on April 6, 2026 · Persbericht

11/03 · SLNO SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026 · Persbericht

11/03 · INO SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026 · Persbericht

11/03 · RARE SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Ultragenyx Pharmaceutical (RARE) Investors of Securities Class Action Deadline on April 6, 2026 · Persbericht

11/03 · QURE SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds uniQure (QURE) Investors of Securities Class Action Deadline on April 13, 2026 · Persbericht

11/03 · VTGN SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Vistagen Therapeutics (VTGN) Investors of Securities Class Action Deadline on March 16, 2026 · Persbericht

11/03 · Lost Money on Agios Pharmaceuticals, Inc.(AGIO)? Contact Levi & Korsinsky Regarding an Ongoing Investigation · Persbericht

11/03 · LEVI & KORSINSKY, LLP: CEO AND CMO NAMED AS CONTROL PERSON DEFENDANTS IN ULTRAGENYX PHARMACEUTICAL SECURITIES ACTION · Persbericht

11/03 · TBPH: Reported $22M in Operating Expenses While Advancing Trial Enrollment -- LEVI & KORSINSKY, LLP Investigates · Persbericht

11/03 · Investors who lost money on REGENXBIO Inc.(RGNX) should contact Levi & Korsinsky about pending Class Action - RGNX · Persbericht

Mijn selecties